Navigation Links
Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month
Date:8/11/2009

AUSTIN, Texas, Aug. 11 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, begins a month long celebration of Texas plasma donors in recognition of the state resolution designating August 2009 as "Plasma Protein Therapies Month." Grifols owns and operates 17 plasma donor facilities throughout the state of Texas and more than 80 across the United States. Grifols' national testing laboratory, headquartered in Austin, Texas, performs more than 1 million tests each month to assure the health and safety of Grifols' donors and the medicines produced from their plasma donations.

"We applaud the Texas House of Representatives for designating August as Plasma Protein Therapies Month and thank the thousands of Texas plasma donors who make treatment possible for many patients who depend on plasma medicines," said company spokesman Christopher Healey. "Too often, people with rare diseases go unnoticed and undertreated; this will go a long way to raise public awareness of these medicines and the conditions they treat."

Plasma donated at Grifols facilities is used to produce therapies such as intravenous immune globulin (IVIG) to treat primary immune deficiency, blood clotting factors to treat hemophilia and other bleeding disorders, and albumin, which is used for shock, trauma, and burns. Patients with a primary immune deficiency suffer with a severely compromised immune system that makes them susceptible to debilitating and potentially life-threatening infections and diseases. Individuals with hemophilia and related bleeding disorders are lacking the essential blood proteins necessary for their blood to properly clot. For these conditions and others, regular and life-long treatment with plasma therapies is often the only treatment option.

For more information about donating plasma and its life-saving properties please visit www.donatingplasma.org.

About Grifols

Grifols SA (Grifols) is a global healthcare company founded in 1940 in Barcelona, Spain. Today Grifols products and services are provided in more than 90 countries around the world. Grifols specializes in the production of plasma therapies to treat a variety of rare and often life-threatening diseases and conditions. Grifols operates 80 plasma donor centers throughout the US and has manufacturing and testing facilities located in Barcelona, Spain, Austin, Texas, and Los Angeles, California.


'/>"/>
SOURCE Grifols, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
2. Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona
3. Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries
4. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
5. Thirteen Courage Center Youth Athletes Take Top Honors in National Sports Competition
6. National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010
7. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
8. THA Honors 12 Legislators for Contributions to Health Care
9. School of Health Management Honors 162 Graduating Students
10. Award Honors Chicago Cancer Survivor Who Gives Back
11. California Association of Physician Groups Honors Heritage Provider Networks With Elite Status of Care Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology: